Free Trial
Final Hours! Save $100 on MarketBeat All Access Before 11:59 PM
  • 0Days
  • 0Hours
  • 0Minutes
  • 0Seconds
Lock In $149 Tonight
Claim MarketBeat All Access Sale Promotion

Concorde International Group (CIGL) Competitors

$0.67 -0.03 (-4.03%)
As of 05/22/2026
Compare

CIGL vs. ATLN, MXCT, SCOR, OPRX, and SKLZ

Should you buy Concorde International Group stock or one of its competitors? MarketBeat compares Concorde International Group with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Concorde International Group include Atlantic International (ATLN), MaxCyte (MXCT), comScore (SCOR), OptimizeRx (OPRX), and Skillz (SKLZ). These companies are all part of the "business services" industry.

How does Concorde International Group compare to Atlantic International?

Concorde International Group (NASDAQ:CIGL) and Atlantic International (NASDAQ:ATLN) are both small-cap business services companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, risk, media sentiment, dividends, institutional ownership, analyst recommendations, profitability and earnings.

Atlantic International has higher revenue and earnings than Concorde International Group.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Concorde International Group$11.07M1.35-$83.64MN/AN/A
Atlantic International$435.88M0.26-$59.43M-$1.09N/A

Concorde International Group has a net margin of 0.00% compared to Atlantic International's net margin of -13.64%.

Company Net Margins Return on Equity Return on Assets
Concorde International GroupN/A N/A N/A
Atlantic International -13.64%N/A -54.43%

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Concorde International Group
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Atlantic International
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
1 Strong Buy rating(s)
2.33

In the previous week, Concorde International Group had 2 more articles in the media than Atlantic International. MarketBeat recorded 2 mentions for Concorde International Group and 0 mentions for Atlantic International. Concorde International Group's average media sentiment score of 1.77 beat Atlantic International's score of 0.00 indicating that Concorde International Group is being referred to more favorably in the media.

Company Overall Sentiment
Concorde International Group Very Positive
Atlantic International Neutral

Summary

Concorde International Group beats Atlantic International on 5 of the 9 factors compared between the two stocks.

How does Concorde International Group compare to MaxCyte?

MaxCyte (NASDAQ:MXCT) and Concorde International Group (NASDAQ:CIGL) are both small-cap business services companies, but which is the better business? We will compare the two companies based on the strength of their earnings, institutional ownership, dividends, media sentiment, profitability, analyst recommendations, risk and valuation.

In the previous week, Concorde International Group had 1 more articles in the media than MaxCyte. MarketBeat recorded 2 mentions for Concorde International Group and 1 mentions for MaxCyte. Concorde International Group's average media sentiment score of 1.77 beat MaxCyte's score of 0.00 indicating that Concorde International Group is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
MaxCyte
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Concorde International Group
2 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

MaxCyte has higher revenue and earnings than Concorde International Group.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
MaxCyte$33.03M3.37-$44.63M-$0.37N/A
Concorde International Group$11.07M1.35-$83.64MN/AN/A

MaxCyte currently has a consensus price target of $5.50, indicating a potential upside of 428.85%. Given MaxCyte's stronger consensus rating and higher probable upside, research analysts clearly believe MaxCyte is more favorable than Concorde International Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
MaxCyte
1 Sell rating(s)
2 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.20
Concorde International Group
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Concorde International Group has a net margin of 0.00% compared to MaxCyte's net margin of -121.16%. Concorde International Group's return on equity of 0.00% beat MaxCyte's return on equity.

Company Net Margins Return on Equity Return on Assets
MaxCyte-121.16% -20.03% -17.14%
Concorde International Group N/A N/A N/A

68.8% of MaxCyte shares are owned by institutional investors. 4.1% of MaxCyte shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

MaxCyte beats Concorde International Group on 8 of the 13 factors compared between the two stocks.

How does Concorde International Group compare to comScore?

comScore (NASDAQ:SCOR) and Concorde International Group (NASDAQ:CIGL) are both small-cap business services companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, dividends, risk, earnings, analyst recommendations, media sentiment, valuation and profitability.

comScore has a net margin of 24.81% compared to Concorde International Group's net margin of 0.00%. comScore's return on equity of 230.75% beat Concorde International Group's return on equity.

Company Net Margins Return on Equity Return on Assets
comScore24.81% 230.75% 23.84%
Concorde International Group N/A N/A N/A

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
comScore
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
Concorde International Group
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

In the previous week, comScore had 1 more articles in the media than Concorde International Group. MarketBeat recorded 3 mentions for comScore and 2 mentions for Concorde International Group. Concorde International Group's average media sentiment score of 1.77 beat comScore's score of 0.34 indicating that Concorde International Group is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
comScore
0 Very Positive mention(s)
2 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Concorde International Group
2 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

42.2% of comScore shares are held by institutional investors. 11.1% of comScore shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

comScore has higher revenue and earnings than Concorde International Group.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
comScore$357.47M0.27-$10M$2.342.74
Concorde International Group$11.07M1.35-$83.64MN/AN/A

Summary

comScore beats Concorde International Group on 10 of the 12 factors compared between the two stocks.

How does Concorde International Group compare to OptimizeRx?

Concorde International Group (NASDAQ:CIGL) and OptimizeRx (NASDAQ:OPRX) are both small-cap business services companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, media sentiment, dividends, earnings, risk, analyst recommendations, valuation and institutional ownership.

OptimizeRx has a net margin of 6.37% compared to Concorde International Group's net margin of 0.00%. OptimizeRx's return on equity of 10.86% beat Concorde International Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Concorde International GroupN/A N/A N/A
OptimizeRx 6.37%10.86%7.93%

OptimizeRx has a consensus price target of $13.43, suggesting a potential upside of 171.83%. Given OptimizeRx's stronger consensus rating and higher probable upside, analysts plainly believe OptimizeRx is more favorable than Concorde International Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Concorde International Group
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
OptimizeRx
1 Sell rating(s)
2 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.56

OptimizeRx has higher revenue and earnings than Concorde International Group.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Concorde International Group$11.07M1.35-$83.64MN/AN/A
OptimizeRx$109.43M0.85$5.13M$0.3514.11

76.5% of OptimizeRx shares are held by institutional investors. 5.6% of OptimizeRx shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

In the previous week, OptimizeRx had 1 more articles in the media than Concorde International Group. MarketBeat recorded 3 mentions for OptimizeRx and 2 mentions for Concorde International Group. Concorde International Group's average media sentiment score of 1.77 beat OptimizeRx's score of 0.33 indicating that Concorde International Group is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Concorde International Group
2 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
OptimizeRx
1 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

OptimizeRx beats Concorde International Group on 11 of the 13 factors compared between the two stocks.

How does Concorde International Group compare to Skillz?

Concorde International Group (NASDAQ:CIGL) and Skillz (NYSE:SKLZ) are both small-cap business services companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, media sentiment, valuation, risk, earnings, dividends, analyst recommendations and institutional ownership.

Skillz has higher revenue and earnings than Concorde International Group.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Concorde International Group$11.07M1.35-$83.64MN/AN/A
Skillz$104.50M1.28-$70.41M-$3.48N/A

Concorde International Group has a net margin of 0.00% compared to Skillz's net margin of -48.49%. Concorde International Group's return on equity of 0.00% beat Skillz's return on equity.

Company Net Margins Return on Equity Return on Assets
Concorde International GroupN/A N/A N/A
Skillz -48.49%-52.81%-20.87%

In the previous week, Skillz had 5 more articles in the media than Concorde International Group. MarketBeat recorded 7 mentions for Skillz and 2 mentions for Concorde International Group. Concorde International Group's average media sentiment score of 1.77 beat Skillz's score of 0.44 indicating that Concorde International Group is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Concorde International Group
2 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
Skillz
1 Very Positive mention(s)
2 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Skillz has a consensus price target of $15.00, suggesting a potential upside of 75.01%. Given Skillz's stronger consensus rating and higher possible upside, analysts plainly believe Skillz is more favorable than Concorde International Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Concorde International Group
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Skillz
1 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.33

19.4% of Skillz shares are held by institutional investors. 59.4% of Skillz shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Summary

Skillz beats Concorde International Group on 8 of the 13 factors compared between the two stocks.

Get Concorde International Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for CIGL and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CIGL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CIGL vs. The Competition

Export
MetricConcorde International GroupPROTECTION IndustryIndustrials SectorNASDAQ Exchange
Market Cap$14.92M$3.42B$9.38B$12.34B
Dividend YieldN/A2.58%3.56%5.28%
P/E RatioN/A18.8625.1022.89
Price / Sales1.355.144,734.4486.28
Price / CashN/A25.7127.5956.67
Price / BookN/A3.585.047.14
Net Income-$83.64M$106.44M$792.97M$335.98M
7 Day Performance-47.35%2.87%1.17%3.56%
1 Month Performance-55.95%-1.39%2.13%2.54%
1 Year Performance-88.73%-11.71%32.13%35.05%

Concorde International Group Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CIGL
Concorde International Group
N/A$0.67
-4.0%		N/A-88.7%$14.92M$11.07MN/A134
ATLN
Atlantic International
0.5125 of 5 stars		$1.43
+0.7%		N/A-39.3%$112.69M$435.88MN/A7
MXCT
MaxCyte
2.239 of 5 stars		$1.06
+1.9%		$5.50
+418.9%		-52.5%$111.41M$32.29MN/A80
SCOR
comScore
1.4936 of 5 stars		$6.20
-4.8%		N/A+32.0%$98.02M$357.47M2.651,200
OPRX
OptimizeRx
4.4248 of 5 stars		$5.09
-2.3%		$13.43
+163.8%		-57.6%$97.77M$109.43M14.54100

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:CIGL) was last updated on 5/25/2026 by MarketBeat.com Staff.
From Our Partners
SpaceX eyes a 1.75 trillion valuation - here's what to know
Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...
Brownstone Research | Sponsoredtc pixel
$30 stock to buy before Starlink goes public (WATCH NOW!)
In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...
Paradigm Press | Sponsoredtc pixel
Your book attached
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...
Profits Run | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
SpaceX IPO hides a much bigger story
The SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...
Weiss Ratings | Sponsoredtc pixel
SpaceX will mint billionaires. You won't be one of them.
By the time a company goes public, 95% of profits have already been made. Insiders bought SpaceX at $20 billio...
Behind the Markets | Sponsoredtc pixel
Satellite Images Spot Potential $10 Trillion Discovery
'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...
Altimetry | Sponsoredtc pixel
Hey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...
After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...
Banyan Hill Publishing | Sponsoredtc pixel